MA (Cantab), PhD, EPA
Rose is driven by a passion for science and combining scientific knowledge with practical IP solutions. Rose brings over a decade of pharmaceutical and biotech patent expertise to evolve, including both law firm experience and six years working in-house at AstraZeneca. Rose’s passion for science stems back to her PhD in immunology and infectious disease at UCL, working on the innate immune responses of macrophages to viral infection (and macrophages remain her favourite cell!).
At AstraZeneca, Rose led IP strategy for products at every-stage of the pipeline, including on-market assets. She was responsible for developing and executing the IP strategy for the biopharma cell therapy department and the neuroscience division. Rose has also completed due diligence and negotiated IP terms for high-profile transactions in the biopharma and oncology space, including cell therapy platform deals. Rose provides invaluable industry expertise to address the unique challenges of IP strategy in the life sciences sector.
When she is not working, Rose is a keen tennis player, cook and gardener, and proud three-times winner of the best roses in the village. Rose also enjoys gundog training with her growing puppy.